Positions and statements

The International Medication Safety Network issues recommendations to regulators, pharmaceutical industry and healthcare providers in several domains such as medication error reporting and learning, unsafe medicines naming, labeling and packaging, etc.

Pharmacovigilance and medication error reporting and learning programmes
Adverse drug reactions and medication errors are two sides of the same coin: medication safety. Cooperation between pharmacovigilance and medication error or patient safety incident reporting systems should be improved. Read more...

Safer medicines naming
The prevention of medication errors related to similar medicines names requires both pre- and post-marketing strategies and involves drug regulatory agencies, pharmaceutical manufacturers, medication error reporting programmes, health care practitioners and patients. Read more...

Safer labelling and packaging
Guidance for safe design of medicines labels and packaging should be developed, improved and used by the pharmaceutical industry, medicine regulators and healthcare providers when developing and risk assessing medicines labelling and packaging. Read more...